Roivant to announce Q3 2026 financial results

Avacta secures FDA clearance for second pre|CISION oncology programme

OncoHost receives BIG Innovation Award in Health category

AbbVie licenses PD-1/VEGF bispecific antibody RC148 from RemeGen in multi-billion dollar oncology deal

Summit Therapeutics and GSK form collaboration to study ivonescimab combination therapy

Summit Therapeutics submits FDA application for ivonescimab in EGFR-mutated lung cancer

Clover Biopharmaceuticals enrols first participants in Phase 2 trial of respiratory combination vaccine candidates

Antin to acquire clinical trial equipment provider Emsere

Merck completes acquisition of Cidara Therapeutics for USD9.2bn

Bambusa Therapeutics reports first patient dosed in proof-of-concept COPD trial

Kelun-Biotech lung cancer drug granted Breakthrough Therapy Designation in China

INOVIO's INO-3107 Biologics License Application accepted by US FDA

Italfarmaco and JCR PHarmaceuticals strike Japan deal for givinostat and expand rare disease collaboration

Sanofi and Regeneron's Dupixent gains Japan approval for paediatric asthma patients aged 6 to 11

Aqualung Therapeutics' Phase 2a lung fibrosis study approved by US FDA